V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240002846 | 240009675 | 1.65 | 15.3 | Adjuvant (A) | null | 2022-04-01 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | N | METHOTREXATE + VINBLASTINE | 100462976 |
| 240002847 | 240009676 | 1.67 | 61 | null | 2021-11-25 | 2021-11-25 | CYCLOPHOSPHAMIDE + FLUDARABINE + THIOTEPA | 02 | null | AML DOWNS HAM | 100938743 |
| 240002849 | 240009677 | null | 87.1 | null | 2017-09-30 | 2017-10-25 | CAR-T Yescarta + Fludarabine + Cyclophosphamide | Y | null | CARBOPLATIN + VINCRISTINE | 101758104 |
| 240000237 | 240009680 | 1.8 | 66 | Curative (C) | 2021-09-22 | 2021-09-30 | null | 02 | N | CYTARABINE + ETOPOSIDE + IFOSFAMIDE | 100510652 |
| 240000612 | 240009685 | 1.65 | 81.4 | null | null | 2020-08-23 | AML MyeChild | 01 | null | CYCLOPHOSPHAMIDE + RITUXIMAB | 101716921 |
| 240000626 | 240009686 | null | 97.5 | Palliative (P) | 2017-10-17 | 2017-10-20 | Venetoclax | 02 | N | CYTARABINE + DAUNORUBICIN | 101019381 |
| 240000708 | 240009687 | 1.7 | 73.4 | null | null | 2021-11-09 | Cytarabine High Dose | N | null | CYTARABINE HIGH DOSE | 101863435 |
| 240001015 | 240009689 | 1.59 | 9.95 | null | 2016-06-23 | 2016-07-27 | Venetoclax | null | null | CLADRIBINE | 101156464 |
| 240001594 | 240009693 | 1.58 | 110 | null | 2020-02-21 | 2020-03-01 | GEMTUZUMAB OZOGAMICIN | 02 | N | RUXOLITINIB | 101502452 |
| 240001816 | 240009695 | 0 | 0 | Palliative (P) | 2018-09-02 | 2018-09-10 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 02 | N | CNS LGG 2004 03 VINC WEEKLY+ CARBO | 101132644 |
| 240002007 | 240009697 | 1.58 | 80.4 | null | 2018-07-09 | 2018-10-02 | Cytarabine High Dose | 02 | null | NOT MATCHED | 100038688 |
| 240002338 | 240009702 | 1.8 | 86.6 | null | 2018-05-03 | 2018-05-03 | null | 02 | null | TRANSPLANT ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 101804494 |
| 240002801 | 240009703 | 1.52 | 96.9 | Disease modification (D) | 2020-11-08 | 2020-11-15 | NHL IntB NHL ritux2010 GpB COPADM | 02 | N | CYCLOPHOSPHAMIDE + RITUXIMAB | 100815906 |
| 240002831 | 240009704 | 1.45 | 17.3 | Curative (C) | null | 2020-02-19 | IMATINIB | Y | N | UKALL 2011 | 100005624 |
| 240000200 | 240009706 | 1.7 | 71.4 | Disease modification (D) | 2017-03-10 | 2017-03-14 | DACARBAZINE + DOXORUBICIN | 02 | N | NOT MATCHED | 100986903 |
| 240001287 | 240009710 | 1.6 | 74 | Curative (C) | 2020-01-15 | 2020-01-15 | RUXOLITINIB | 02 | null | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 100843054 |
| 240002468 | 240009711 | 1.68 | 68.6 | Curative (C) | 2020-09-15 | 2020-09-18 | ALEMTUZUMAB + CYCLOPHOSPHAMIDE + FLUDARABINE | 02 | null | TRIAL | 101132559 |
| 240000713 | 240009806 | null | null | null | null | 2018-08-13 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100494196 |
| 240000724 | 240009810 | null | null | null | 2019-12-05 | 2019-12-08 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100833427 |
| 240000738 | 240009811 | 1.65 | 59 | null | null | 2018-02-15 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100312022 |
| 240000819 | 240009837 | null | null | null | null | 2017-03-25 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101098562 |
| 240000837 | 240009841 | null | null | null | null | 2019-01-27 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100962394 |
| 240000838 | 240009842 | null | null | null | null | 2019-04-28 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101718703 |
| 240000866 | 240009849 | null | null | null | null | 2017-10-02 | null | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101710075 |
| 240000921 | 240009872 | null | null | null | null | 2019-09-11 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100958443 |
| 240000924 | 240009875 | null | null | null | null | 2020-03-14 | CHOP R | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100096854 |
| 240000939 | 240009882 | null | null | Curative (C) | null | 2018-02-19 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101248106 |
| 240000948 | 240009886 | null | null | null | null | 2018-03-25 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101636865 |
| 240000957 | 240009890 | null | null | null | null | 2019-02-18 | CHOP R | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100748661 |
| 240001019 | 240009917 | null | null | null | null | 2017-07-05 | CHOP R - 21 days | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100554288 |
| 240001036 | 240009924 | null | null | null | null | 2018-04-18 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100488179 |
| 240001047 | 240009930 | null | null | null | 2017-12-05 | 2017-12-08 | CHOP R | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101566637 |
| 240001050 | 240009931 | null | null | null | null | 2018-06-23 | CHOP R | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100771514 |
| 240001054 | 240009934 | 1.71 | 60 | null | null | 2018-02-04 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101319744 |
| 240001089 | 240009946 | null | null | null | null | 2018-10-25 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100027397 |
| 240001136 | 240009959 | null | null | null | null | 2019-12-15 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100821053 |
| 240001150 | 240009964 | null | null | Curative (C) | null | 2019-11-02 | null | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101047537 |
| 240001183 | 240009978 | null | null | null | null | 2019-10-14 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101714641 |
| 240001191 | 240009981 | null | null | null | null | 2017-05-23 | CHOP R - 14 days | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100073400 |
| 240001195 | 240009982 | null | null | Curative (C) | null | 2016-06-20 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101192626 |
| 240001199 | 240009983 | null | null | null | null | 2017-08-28 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100674767 |
| 240001201 | 240009985 | null | null | null | null | 2018-02-11 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101635703 |
| 240001204 | 240009986 | null | null | null | null | 2016-05-08 | null | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101606493 |
| 240001207 | 240009988 | 1.85 | 67.7 | Curative (C) | null | 2016-10-20 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100621386 |
| 240001210 | 240009991 | 1.76 | 133.3 | null | null | 2021-09-15 | CHOP R | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100128533 |
| 240001218 | 240009996 | null | null | null | null | 2016-02-23 | null | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100712909 |
| 240001223 | 240009999 | null | null | null | null | 2019-01-26 | CHOP R | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100612810 |
| 240001226 | 240010000 | null | null | null | null | 2020-06-08 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100332599 |
| 240001231 | 240010004 | 1.77 | 52.6 | null | null | 2016-01-20 | null | null | null | METHOTREXATE | 100847367 |
| 240001247 | 240010010 | 1.73 | 50.4 | null | 2019-04-30 | 2019-05-07 | Rituximab | 02 | null | RITUXIMAB | 101503144 |